Showing results (31-40 of 161) with videos related to
Sort By:
Pageof 17
MMW Fortschritte Der Medizin|April 16, 2026
[Overview of the relevance of the intestinal mucus layer of the intestinal barrier - current state of knowledge and clinical perspective]Martin Storr, Alina BurghardMicroorganisms|June 26, 2026
Viable and Heat-Inactivated Bifidobacterium bifidum MIMBb75 Protect the Intestinal BarrierMartin Storr, Martin GschwenderThe European Journal of Neuroscience|April 14, 2004
Increased expression of TRPV1 receptor in dorsal root ganglia by acid insult of the rat gastric mucosaRudolf Schicho, Waltraud Florian, Ingrid Liebmann, et al.The European Journal of Neuroscience|January 31, 2004
Immunocytochemical characterization of rat brainstem neurons with vagal afferent input from the stomach challenged by acid or ammoniaMarion Danzer, Claudia Samberger, Rudolf Schicho, et al.Handbook of Experimental Pharmacology|September 27, 2015
Endocannabinoids and the Digestive Tract and Bladder in Health and DiseaseAngelo A Izzo, Giulio G Muccioli, Michael R Ruggieri, et al.Medizinische Klinik (Munich, Germany : 1983)|August 10, 2002
[Using botulinum toxin type A in the gastrointestinal tract]Martin Storr, Hans-Dieter AllescherCanadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 25, 2011
The pathophysiology of chronic constipationChristopher N Andrews, Martin StorrInternational Journal of Molecular Sciences|March 25, 2022
Tumor-Mediated Neutrophil Polarization and Therapeutic ImplicationsSofia Raftopoulou, Paulina Valadez-Cosmes, Zala Nikita Mihalic, et al.Journal of Molecular Medicine (Berlin, Germany)|September 1, 2005
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tractFederico Massa, Martin Storr, Beat LutzTherapeutic Advances in Gastroenterology|September 2, 2015
The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspectivePaula Mosińska, Martin Storr, Jakub FichnaPageof 17